IOVA | Iovance Biotherapeutics Inc.
Category: Consumer goods
Quick infos Headquarters: San Carlos, California, United States Trade prices Volume: Market Cap: 1.8B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: February 28, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast May 9, 2023 February 28, 2023 -0.64 / -0.64- / -November 9, 2022 - / -0.6379- / -August 4, 2022 -0.63 / -0.6064- / -May 5, 2022 -0.58 / -0.6368- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 4, 2022 12.54 12.23 12.54
11.97
2.67M 4.15% Aug 3, 2022 12.04 11.71 12.53
11.71
2.68M 4.70% Aug 2, 2022 11.50 11.07 11.58
11.02
2.02M 3.42% Aug 1, 2022 11.12 11.62 11.71
10.99
2.36M -4.55% Jul 29, 2022 11.65 11.72 11.72
11.21
2.16M 0% Jul 28, 2022 11.65 12.18 12.21
11.06
2.86M -4.12% Jul 27, 2022 12.15 12.12 12.23
11.72
2.67M 1.25% Jul 26, 2022 12.00 11.81 12.36
11.77
1.65M 0.17% Jul 25, 2022 11.98 11.92 12.05
11.57
1.68M 1.70% Jul 22, 2022 11.78 12.64 12.84
11.74
2.44M -5.91% view more
IOVA
More profiles and info about the company News
Iovance Biotherapeutics to Present at Upcoming Conferences finance.yahoo.com Mar 11, 2023 8:03 am Cara, Iovance, and Karyopharm among biotechs with no exposure to SVB (updated) seekingalpha.com Mar 11, 2023 6:31 am
Great week for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) institutional investors after losing 43% over the previous year finance.yahoo.com Mar 4, 2023 8:13 am
Q4 2022 Iovance Biotherapeutics Inc Earnings Call finance.yahoo.com Mar 1, 2023 12:33 pm Iovance Biotherapeutics GAAP EPS of -$0.64 in-line seekingalpha.com Mar 1, 2023 5:10 am
Drug, Biotech Stocks' Q4 Earnings on Feb 28: NVAX, IOVA & More finance.yahoo.com Feb 27, 2023 9:31 am
Iovance Biotherapeutics Acquires Clinigen's IL-2 Product For Upfront £166.7M finance.yahoo.com Jan 30, 2023 11:39 am
Iovance's stock is down after receiving FDA feedback on application for new melanoma drug finance.yahoo.com Jan 30, 2023 9:00 am Iovance gains as Piper sees approval for melanoma therapy this year seekingalpha.com Jan 27, 2023 11:02 pm
Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6% finance.yahoo.com Jan 24, 2023 12:15 pm Why Iovance Biotherapeutics Was Halved Today fool.com Dec 22, 2022 1:08 pm Iovance's stock is down after receiving FDA feedback on application for new melanoma drug marketwatch.com Dec 22, 2022 9:00 am Iovance downgraded at Goldman Sachs citing concerns on lead asset seekingalpha.com Dec 10, 2022 12:07 am Iovance adds 21% on $65M insider purchase seekingalpha.com Dec 5, 2022 8:34 pm Iovance falls 12% as rolling review filing extended after FDA seeks more data seekingalpha.com Nov 18, 2022 8:28 pm Why Iovance Biotherapeutics Is Crashing Today fool.com Nov 18, 2022 1:06 pm Iovance Bio rises 9% after acquiring worldwide rights to cancer therapy Proleukin for ~£208.4M seekingalpha.com Jan 23, 2023 10:22 pm
Iovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancers (SITC) 37th Annual Meeting finance.yahoo.com Dec 22, 2022 8:05 am
Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma finance.yahoo.com Dec 22, 2022 7:30 am
12 Stocks Insiders are Buying Now finance.yahoo.com Dec 16, 2022 9:54 am This company doesn't provide a dividend.
Key Persons CEO : Maria Fardis CFO : Timothy E Morris Talk about Iovance Biotherapeutics Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 90 HOLD 10 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?